{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:00:54Z","timestamp":1777525254765,"version":"3.51.4"},"reference-count":62,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr (Phila)"],"published-print":{"date-parts":[[2010,9]]},"abstract":"<jats:p>Attention-deficit hyperactivity disorder (ADHD) is a common neurobehavioral disorder that is often treated with stimulants such as methylphenidate and mixed amphetamine salts. Despite their efficacy and long history of use, there is concern about their potential for adverse cardiovascular effects in children and adolescents. Data from placebo-controlled and open-label extension trials published after 2000 were reviewed, and cardiovascular adverse event data were compared. Both placebo-controlled and open-label extension trials have repeatedly shown stimulant-induced increases in mean blood pressure, heart rate, and QT interval in children, adolescents, and adults. Although these increases seem relatively minor, their existence raises questions regarding whether stimulants could influence the likelihood of sudden death or other serious cardiovascular consequences, especially in patients with underlying heart problems. Moreover, questions have been raised regarding the necessity of screening patients for occult or unrecognized heart problems that are felt to be adversely affected by stimulant use. Obtaining a baseline electrocardiogram for any patient starting stimulant treatment is reasonable if access to such screening is readily available and not too costly.<\/jats:p>","DOI":"10.1177\/0009922810368289","type":"journal-article","created":{"date-parts":[[2010,8,7]],"date-time":"2010-08-07T01:23:04Z","timestamp":1281144184000},"page":"840-851","source":"Crossref","is-referenced-by-count":17,"title":["Cardiovascular Safety of Stimulant Medications for Pediatric Attention-Deficit Hyperactivity Disorder"],"prefix":"10.1177","volume":"49","author":[{"given":"Raul R.","family":"Silva","sequence":"first","affiliation":[{"name":"New York University Langone Medical Center, New York, NY, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey W.","family":"Skimming","sequence":"additional","affiliation":[{"name":"Pediatrix Medical Group, Weston, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Muniz","sequence":"additional","affiliation":[{"name":"US Clinical Developmental & Medical Affairs, Neuroscience, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2010,8,1]]},"reference":[{"key":"atypb1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ambp.2006.07.006"},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.105.5.1158"},{"key":"atypb3","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/CIRCULATIONAHA.107.189473","volume":"117","author":"Vetter VL","year":"2008","journal-title":"Circulation"},{"key":"atypb4","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-1573"},{"key":"atypb5","doi-asserted-by":"publisher","DOI":"10.1097\/DBP.0b013e31318185dc14"},{"key":"atypb6","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2009.09040472"},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp068049"},{"key":"atypb8","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1340-7"},{"key":"atypb9","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(94)01085-Y"},{"key":"atypb10","first-page":"214","volume":"170","author":"Albertson TE","year":"1999","journal-title":"West J Med"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.1097\/01.smj.0000168701.08879.3f"},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1556-4029.2008.00949.x"},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2005.03.014"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200105000-00011"},{"key":"atypb15","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900014115"},{"key":"atypb16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.11.043"},{"key":"atypb17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.09.011"},{"key":"atypb18","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0215"},{"key":"atypb19","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-005-2051-1"},{"key":"atypb20","first-page":"19","volume":"41","author":"Silva R.","year":"2008","journal-title":"Psychopharmacol Bull"},{"key":"atypb21","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2007.0015"},{"key":"atypb22","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2006.16.239"},{"key":"atypb23","doi-asserted-by":"publisher","DOI":"10.1017\/S109285290000242X"},{"key":"atypb24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.05.002"},{"key":"atypb25","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000106223.36344.df"},{"key":"atypb26","doi-asserted-by":"publisher","DOI":"10.1177\/1087054708320397"},{"key":"atypb27","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01472-9"},{"key":"atypb28","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2005.07.012"},{"key":"atypb29","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00999.2007"},{"key":"atypb30","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.08.023"},{"key":"atypb31","volume-title":"E14 clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs","author":"Food and Drug Administration.","year":"2005"},{"key":"atypb32","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(93)90036-C"},{"key":"atypb33","doi-asserted-by":"publisher","DOI":"10.1177\/107424840400900107"},{"key":"atypb34","first-page":"447","volume":"4","author":"Jenzer HR","year":"1976","journal-title":"Eur J Cardiol"},{"key":"atypb35","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(84)90081-4"},{"key":"atypb36","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200009000-00016"},{"key":"atypb37","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2009.01.003"},{"key":"atypb38","doi-asserted-by":"publisher","DOI":"10.1016\/S1056-8719(03)00008-X"},{"key":"atypb39","doi-asserted-by":"publisher","DOI":"10.1016\/j.chc.2007.11.010"},{"key":"atypb40","volume-title":"Paper presented at: The American Psychiatric Association Annual Meeting","author":"Teneggi V."},{"key":"atypb41","volume-title":"Safety review: follow up review of AERS search identifying cases of sudden death occurring with drugs used for the treatment of attention deficit hyperactivity disorder (ADHD)","author":"Villalba L."},{"key":"atypb42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604183341607"},{"key":"atypb43","volume-title":"Concerta [package insert]","year":"2007"},{"key":"atypb44","volume-title":"Daytrana [package insert]","year":"2008"},{"key":"atypb45","volume-title":"Focalin XR [package insert]","year":"2007"},{"key":"atypb46","unstructured":"Ritalin LA [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 1007."},{"key":"atypb47","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.107.181423","volume":"115","author":"Maron BJ","year":"2007","journal-title":"Circulation"},{"key":"atypb48","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.108.825232"},{"key":"atypb49","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000114144.40315.C0"},{"key":"atypb50","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2004.04.017"},{"key":"atypb51","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.03.007"},{"key":"atypb52","doi-asserted-by":"publisher","DOI":"10.4065\/73.3.250"},{"key":"atypb53","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(99)70140-7"},{"key":"atypb54","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.65.7.1388"},{"key":"atypb55","doi-asserted-by":"publisher","DOI":"10.3310\/hta9440"},{"key":"atypb56","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl115"},{"key":"atypb57","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-0942"},{"key":"atypb58","doi-asserted-by":"publisher","DOI":"10.1017\/S1355617702801345"},{"key":"atypb59","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200403000-00007"},{"key":"atypb60","doi-asserted-by":"publisher","DOI":"10.1017\/S003329170500471X"},{"key":"atypb61","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.12.1792"},{"key":"atypb62","doi-asserted-by":"publisher","DOI":"10.1136\/oem.2007.038448"}],"container-title":["Clinical Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0009922810368289","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0009922810368289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:25:36Z","timestamp":1777393536000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0009922810368289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,1]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["10.1177\/0009922810368289"],"URL":"https:\/\/doi.org\/10.1177\/0009922810368289","relation":{},"ISSN":["0009-9228","1938-2707"],"issn-type":[{"value":"0009-9228","type":"print"},{"value":"1938-2707","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,1]]}}}